688235
Beigene Says Company's Nasdaq Stock Code Will Be Changed to Onc From Bgne From Jan 2
时间：2024-12-23 19:06:09 市场： 综合
Beigene - Will Change Its Nasdaq Ticker Symbol for Its American Depositary Shares From "Bgne" to "Onc" on Jan 2, 2025
时间：2024-12-23 19:05:51 市场： 综合
JPMorgan Chase & Co's Short Position in Shares of Beigene Decreases to 1.66% on Dec. 11 From 2.42% - HKEX
时间：2024-12-16 17:29:49 市场： 综合
港股生物医药股集体下跌，再鼎医药(09688.HK)跌超7%，百济神州(06160.HK)、药明合联(02268.HK)跌超2%，药明康德(02359.HK)跌超1%。
时间：2024-12-05 09:53:36 市场： 美股 综合 港股
European Commission Approves Beigene’s Tevimbra for First-Line Treatment of Advanced/Metastatic Esophageal Squamous Cell Carcinoma and Gastric or Gastroesophageal Junction Cancer
时间：2024-11-27 19:00:00 市场： 综合
Labcorp CFO Glenn Eisenberg Announces Plans to Retire
时间：2024-11-19 20:00:15 市场： 美股 综合
Beigene Announces Settlement of Litigation Against Generic Filer of Brukinsa
时间：2024-11-19 19:00:00 市场： 综合
Beigene Unveils Proposed Name Change to Beone Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer
时间：2024-11-14 19:00:07 市场： 综合
Beigene Ltd : Jefferies Raises Target Price to $286 From $284
时间：2024-11-13 21:05:32 市场： 美股 综合
Beigene Receives Positive Chmp Opinions for Tevimbra® as a First-Line Treatment for Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer and Esophageal Squamous Cell Carcinoma
时间：2024-10-21 18:00:00 市场： 综合